Risk of cytomegalovirus infection in paediatric allogeneic stem cell transplants

被引：0
|
作者：
Haastrup, E
Müller, K
Jacobsen, N
Lauersen, HB
Heilmann, C
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants
    Allaw, Fatima
    Haddad, Sara F.
    Zakhour, Johnny
    Kanj, Souha S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (02)
  • [2] Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
    Meijer, E
    Boland, GJ
    Verdonck, LF
    CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (04) : 647 - +
  • [3] Cytomegalovirus (CMV) surveillance and infection in allogeneic bone marrow and blood stem cell transplants.
    Tarantolo, SR
    Walters, T
    Reed, EC
    Bishop, MR
    Armitage, JO
    Bierman, PJ
    Vose, JM
    Rennard, SI
    Kessinger, A
    BLOOD, 1995, 86 (10) : 848 - 848
  • [4] SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTS IN PAEDIATRIC PATIENTS
    Paumard, Rodriguez Elena
    Fernandez, Camacho Inmaculada
    Salas, Hernandez Francisco
    Rodriguez, Villa Antonia
    Martin, Calvo Carmen
    Rojas, Contreras Rafael
    Garcia, Torres Estefania
    Molina, Hurtado Jose Ramon
    HAEMATOLOGICA, 2020, 105 : 269 - 269
  • [5] Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation
    David Nachbaur
    Clara Larcher
    Brigitte Kircher
    Günther Eibl
    Walter Nussbaumer
    Eberhard Gunsilius
    Margot Haun
    Kurt Grünewald
    Günther Gastl
    Annals of Hematology, 2003, 82 : 621 - 627
  • [6] Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation
    Nachbaur, D
    Larcher, C
    Kircher, B
    Eibl, G
    Nussbaumer, W
    Gunsilius, E
    Haun, M
    Grünewald, K
    Gastl, G
    ANNALS OF HEMATOLOGY, 2003, 82 (10) : 621 - 627
  • [7] Risk for cytomegalovirus infection following non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Gunsilius, E
    Haun, M
    Larcher, C
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S96 - S97
  • [8] Risk factors for cytomegalovirus infection of 79 allogeneic hematopoietic stem cell transplantation patients
    Tan, Y.
    Liu, X.
    Zhao, Y.
    Su, L.
    Liu, Y.
    Gao, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S406 - S406
  • [9] Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants
    Preiser, W
    Bräuninger, S
    Schwerdtfeger, R
    Ayliffe, U
    Garson, JA
    Brink, NS
    Franck, S
    Doerr, HW
    Rabenau, HF
    JOURNAL OF CLINICAL VIROLOGY, 2001, 20 (1-2) : 59 - 70
  • [10] Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants
    Lacey, SF
    Diamond, DJ
    Zaia, YA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (07) : 433 - 447
12345